#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17352	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2147	802.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1454	1454	C	970	C,T	920,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30926	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	863.2	0	.	n	.	0	T695C	SNP	695	695	T	1116	1116	C	911	C,A	864,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30926	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	863.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	2059	2059	G	989	G,A,C	717,224,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30926	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	863.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2392	2392	C	1008	C	941	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30926	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	863.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2466	2466	A	1040	A	990	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30926	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	863.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3018	3018	C	915	C	875	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30926	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	863.2	0	HET	.	.	.	T2085C	.	2085	2085	T	2506	2506	T	1020	T,C	506,455	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2416	folP	855	855	100.0	folP.l15.c4.ctg.1	1535	156.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1088	1090	AGC	229;228;228	A;G;C	219;222;220	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6156	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3467	176.9	1	SNP	p	S91F	1	.	.	271	273	TTC	660	662	TTC	212;213;212	T;T;C,T	202;204;199,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6156	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3467	176.9	1	SNP	p	G95N	0	.	.	283	285	GGC	672	674	GGC	200;200;201	G;G;C	193;193;189	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6156	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3467	176.9	1	SNP	p	D95G	1	.	.	283	285	GGC	672	674	GGC	200;200;201	G;G;C	193;193;189	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1916	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1446	131.9	1	SNP	p	G45D	0	.	.	133	135	GGC	529	531	GGC	245;245;249	G;G;C	230;230;233	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1038	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1016	101.3	0	.	n	.	0	A197.	DEL	197	197	A	596	596	A	262	A	245	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2983	199.5	1	SNP	p	D86N	0	.	.	256	258	GAC	622	624	GAC	246;246;250	G;A;C	237;234;238	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2983	199.5	1	SNP	p	R87I	0	.	.	259	261	CGT	625	627	CGT	251;248;252	C;G;T	240;236;238	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2983	199.5	1	SNP	p	R87W	0	.	.	259	261	CGT	625	627	CGT	251;248;252	C;G;T	240;236;238	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2983	199.5	1	SNP	p	S87R	1	.	.	259	261	CGT	625	627	CGT	251;248;252	C;G;T	240;236;238	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5978	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2983	199.5	1	SNP	p	S88P	0	.	.	262	264	TCC	628	630	TCC	251;252;253	T;C;C	236;239;242	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5224	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2714	191.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1531	1533	GGC	281;281;278	G;G;C	260;259;257	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4860	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2527	191.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1301	1303	GCC	249;249;252	G;C;C	243;240;244	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4860	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2527	191.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1304	1306	ATG	254;254;258	A;T;G	245;247;252	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4860	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2527	191.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1316	1318	ACC	253;254;252	A;C;C	242;243;243	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4860	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2527	191.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1316	1318	ACC	253;254;252	A;C;C	242;243;243	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4860	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2527	191.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1817	1819	ACC	292;292;290	A;C;C	267;271;273	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4860	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2527	191.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1871	1873	GCG	247;246;250	G;C;G	234;238;240	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4860	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2527	191.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1871	1873	GCG	247;246;250	G;C;G	234;238;240	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4860	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2527	191.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1994	1996	GGT	204;200;199	G;G;T	188;185;183	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4860	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2527	191.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2003	2005	AGC	187;185;184	A;G;C	175;174;170	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4860	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2527	191.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2021	2023	CCG	154;159;157	C,CGG,CG;C;GCCC,GGCCCC	112,2,1;116;109,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6772	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3125	215.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1639	1641	CCG	246;244;247	C;C;G	224;231;229	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2912	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1947	148.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	621	621	C	217	C	194	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3220	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1522	209.7	0	.	p	.	0	I45L	NONSYN	133	135	ATT	387	389	CTT	249;251;255	C;T;T	239;241;245	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3220	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1522	209.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	903	905	GGT	258;257;257	G;G;T	248;246;240	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3220	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1522	209.7	0	.	p	.	0	G256D	NONSYN	766	768	GGT	1020	1022	GAT	278;280;280	G;A;T	264;265;266	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3220	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1522	209.7	1	SNP	p	G120K	1	.	.	358	360	AAG	612	614	AAG	243;243;244	A;A;G,C	231;231;229,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3220	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1522	209.7	1	SNP	p	N121D	0	.	.	361	363	AAC	615	617	AAC	238;236;241	A,G;A;C,A	222,1;225;226,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3220	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1522	209.7	1	SNP	p	A121N	1	.	.	361	363	AAC	615	617	AAC	238;236;241	A,G;A;C,A	222,1;225;226,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11784	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4901	239.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1350	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1093	122.8	1	SNP	p	V57M	1	.	.	169	171	ATG	526	528	ATG	266;265;264	A;T;G	256;254;251	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
